Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 11;118(Forthcoming):1-7.
doi: 10.3238/arztebl.m2021.0110. Online ahead of print.

Clinical Practice Guideline: Recommendations on Inpatient Treatment of Patients with COVID-19

Collaborators

Clinical Practice Guideline: Recommendations on Inpatient Treatment of Patients with COVID-19

Stefan Kluge et al. Dtsch Arztebl Int. .

Abstract

Background: Since identification of the first cases in December 2019, COVID-19, caused by the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) has spread across the world, giving rise to a global pandemic.

Methods: A literature search was carried out in PubMed, using search terms defined by the authors. Questions important for the management of patients with COVID-19 were identified and discussed, and recommendations or statements on these topics were formulated in a structured consensus process.

Results: Determination of the indication for the admission of COVID-19 patients to the hospital should involve consideration of age, comorbidities, respiratory rate, and oxygen saturation. Every patient admitted without a recent PCR test should be tested immediately. It is recommended that any COVID-19 patient with hypoxemia (SpO2 <90%) despite being given oxygen, dyspnea, or a high respiratory rate be admitted to intensive care. In the case of hypoxemic respiratory insufficiency, an attempt at treatment with high-flow oxygen or non-invasive ventilation is suggested, while patients with severe hypoxemia/high respiratory rate should undergo intubation and invasive ventilation. In the presence of additional risk factors (such as obesity, known thrombophilia, intensive care treatment, or elevated D-dimers), intensified prophylaxis against thromboembolism may be indicated. Treatment with dexamethasone decreases the mortality among patients with severe or critical COVID-19. The important personal protection measures are attention to hygiene and the correct wearing of personal protective equipment.

Conclusion: The principal treatment measures are maintenance of adequate oxygenation, pharmacological prevention of thrombosis, and, in severe cases, administration of dexamethasone.

PubMed Disclaimer

Figures

Figure
Figure
Possible instrument-based treatment escalation in the case of acute respiratory insufficiency as a result of COVID-19 (40) (reprinted with kind permission from Thieme Verlag) RR, respiratory rate; CPAP, continuous positive airway pressure; COPD, continuous positive airway pressure; DNI, do not intubate; NIV, noninvasive ventilation; PEEP, positive end-expiratory pressure; VT, tidal volume

Comment in

  • Oxygen Treatment In Covid-19.
    Gottlieb J, Volk T, Fühner T. Gottlieb J, et al. Dtsch Arztebl Int. 2021 Jun 4;118(22):375-376. doi: 10.3238/arztebl.m2021.0179. Dtsch Arztebl Int. 2021. PMID: 34250894 Free PMC article. No abstract available.
  • Add Vitamin D Supplementation.
    Brenner H. Brenner H. Dtsch Arztebl Int. 2021 Jun 4;118(22):376. doi: 10.3238/arztebl.m2021.0180. Dtsch Arztebl Int. 2021. PMID: 34250895 Free PMC article. No abstract available.

References

    1. Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. [Recommendations for critically ill patients with COVID-19] Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2020;115:175–177. - PMC - PubMed
    1. Robert Koch-Institut. Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19. www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/ Steckbrief.html#do.... (last accessed on 10 December 2020)
    1. Robert Koch-Institut. Aktueller Lage-/Situationsbericht des RKI zu COVID-19. www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/... (last accessed on 10 December 2020)
    1. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55 2000547. - PMC - PubMed
    1. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770. - PMC - PubMed